Home
 
  Email:  
  Password:
  Enter
Forget your password?
 
Reto Rietman, General Manager of Rxmidas
 
 
 
 
 
Sunday, January 4, 2009
Sinovac Hep A vaccine cleared- no involvement in child's death
Wednesday, December 31, 2008
Tighter control of chain outlets prescribed for Nepstar   Free access
Accord to exit retail business, acquire stakes in three other manufacturers
Zhejiang Huahai Pharmaceutical to increase solid prep export capacity
Shanghai Pharmaceutical consolidates Huashi drug store assets
Tuesday, December 30, 2008
Vaccine ADR monitoring center in the works, says China CDC
Tianjin to implement new medical reforms- earmarks RMB 500 million per year   Free access
Children are the future- Shandong Xincat joins move into pediatric drug market
Merro Pharm to build RMB 1.1 billion medicine base in Dalian
Medtronic acquires 15% of Shangdong Weigao Polymer, announces new JV to follow   Free access
NPC allows for compulsory licensing for drugs addressing public health needs
China invests RMB 3.5 billion into TCM industry in 2008
Laobaixing to expand into rural Shaanxi Province   Free access
Monday, December 29, 2008
Draft Social Security Law to allow cross-province insurance, pension portability   Free access
Hypocritical Oath- Guangdong hospital admits to phony physical exam reports   Free access
US FDA gives the skinny on tainted diet pills, many from China
Friday, December 26, 2008
State Information Center: economic slowdown has little impact on pharma industry
BMP Sunstone acquires 50% of Zhangjiakou Shengda
Vitamin B5 battle over- Xinfu drives out upstart Xinfa with lawsuit victory   Free access
Shanghai begins to shift medical resources to suburban areas
Avian flu remains a few hops ahead of vaccine
Thursday, December 25, 2008
Tianjin to introduce centralized procurement in community hospitals
Second draft of new Social Security Law meets resistance
Shinva Medical and GE Healthcare announce new in-vivo diagnostic JV   Free access
China Biologic scores first international sale   Free access
 
 
     About us | Contact us | FAQ | Feedback   © GB Group limited. All right reserved.  
pharmaceutical,china pharmaceutical,pharm,pharmhound,generalbiologic,China drug,Drug discovery,Pharmaceutical market,China Antibody,China preclinical,China clinical trial,China CRO,China API,Matthew Chervenak,China research and development,China hepatitis,China cancer,China diabetes,China oncology,China cardiovascular,China CNS,China disease